-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Michael Wang, MD1, Tadeusz Robak, MD, PhD2, Kami J. Maddocks, MD3, Tycel Phillips, MD4*, Stephen D. Smith, MD5, David Gallinson, DO6*, Roser Calvo7*, Chuan-Chuan Wun, RPh, PhD8*, Veerendra Munugalavadla, PhD8 and Wojciech Jurczak, MD, PhD9*

1MD Anderson Cancer Center, University of Texas, Houston, TX
2Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland
3The James Comprehensive Cancer Center The Ohio State University, Columbus, OH
4University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
5University of Washington/Fred Hutchinson Cancer Research Center, Seattle
6Summit Medical Group, Florham Park, NJ
7AstraZeneca, Gaithersburg, MD
8AstraZeneca, South San Francisco, CA
9Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland

Franck Morschhauser, MD, PhD1*, Loretta J. Nastoupil, MD2, Pierre Feugier, MD, PhD3*, Jean Marc Schiano De Colella4*, Hervé Tilly, MD5, M. Lia Palomba, MD6, Emmanuel Bachy, MD, PhD7*, Christophe Fruchart, MD8*, Edward Libby9, Rene-Olivier Casasnovas, MD10*, Ian W. Flinn, MD, PhD11, Corinne Haioun, MD, PhD12*, Herve Maisonneuve, MD13, Loic Ysebaert, MD, PhD14*, Nancy L. Bartlett, MD15, Kamal Bouabdallah, MD16*, Pauline Brice, MD17*, Vincent Ribrag, MD18, Steven Le Gouill, MD, PhD19*, Nicolas Daguindau, MD20*, Vincent Delwail, MD21*, Gian-Matteo Pica, MD22*, Alejandro Martin Garcia-Sancho23*, Armando Lopez-Guillermo, MD24, Jean-Francois Larouche, MD25, Kiyoshi Ando, MD, PhD26, Gomes da Silva Maria, MD, PhD27*, Marc André, MD28*, Ka Lung Wu, MD29, Laurie H. Sehn, MD30, Koji Izutsu, MD, PhD31*, Guillaume Cartron, MD, PhD32*, Argyrios Gkasiamis, MD33, Russell Crowe33*, Luc Xerri, MD, PhD4*, Nathan H. Fowler, MD2 and Gilles Salles, MD, PhD6

1Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, CHU Lille, Lille, France
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Nancy University Hospital, Vandoeuvre-lès-Nancy, France
4Institut Paoli-Calmettes, Marseille, France
5Centre Henri Becquerel, Rouen, France
6Memorial Sloan Kettering Cancer Center, New York, NY
7Hospices Civils De Lyon, Lyon, France
8CH de Dunkerque, Dunkerque, France
9University of Washington, Seattle, WA
10CHU Dijon-Bourgogne, Dijon, France
11Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
12Henri Mondor University Hospital, UPEC, Créteil, France
13Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
14Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France
15Washington University School of Medicine, St. Louis, MO
16Hôpital Haut-Lévêque, Pessac, France
17Department of Hematology, Hôpital Saint-Louis, Paris, France
18Institut Gustave Roussy, Villejuif, France
19Nantes Medical University, Nantes, France
20Annecy Hospital, Annecy, France
21CHU de Poitiers, Poitiers, France
22Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France
23Hospital Universitario de Salamanca, Salamanca, Spain
24Hospital Clínic de Barcelona, Barcelona, Spain
25CHU de Québec, Québec, QC, Canada
26Tokai University School of Medicine, Isehara, Japan
27Instituto Português de Oncologia de Lisboa, Lisboa, Portugal
28CHU UCL Namur, Yvoir, Belgium
29ZNA Stuivenberg, Antwerp, Belgium
30BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada
31National Cancer Center Hospital, Tokyo, Japan
32CHU Montpellier, Montpellier, France
33Bristol Myers Squibb, Princeton, NJ

Xiaomeng Yue, PhD1*, David Hallett2*, Yangyang Liu2*, Reethi Iyengar2*, Elisa Basa2* and Huiying Yang2*

1Joule, North Chicago, IL
2AbbVie, North Chicago, IL

Yanni Hao, PhD1*, Wei-Chun Hsu2*, Craig S Parzynski2*, C Lobetti Bodoni, MD, PhD3*, Evgeny Degtyarev3*, Lisa Hampson3*, Aisha Masood, MD1 and Wen-Hsing Wu2*

1Novartis Pharmaceuticals Corporation, East Hanover, NJ
2Genesis Research, Hoboken, NJ
3Novartis Pharma AG, Basel, Switzerland

Kirk Cahill, MD1,2, Michael Leukam, MD, MS3,4, Theodore G. Karrison, PhD2,5*, Jessica Robertson, CCRP1*, Justin Kline, MD2,6 and Sonali M. Smith, MD2,7

1Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL
2Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL
3Beth Israel Deaconess Medical Center, Boston, MA
4Department of Medicine, Harvard Medical School, Boston, MA
5Department of Public Health Sciences, University of Chicago, Chicago, IL
6Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
7Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Laurie H. Sehn, MD1, Stefano Luminari, MD2*, Antonio Salar, MD, PhD3*, Björn Wahlin, MD, PhD4, Ajay K Gopal, MD5, Christophe Bonnet, MD, PhD6*, Shankara Paneesha, MD7, Marek Trněný, MD8, Oliver Manzke, MD9*, Francis Seguy, MSc10*, Di Li, PhD11*, Kai Hübel, MD12* and Christian W Scholz, MD13

1Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
2Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
3Department of Haematology, Hospital del Mar-IMIM, Barcelona, Spain
4Karolinska Institute, Stockholm, Sweden
5Division of Medical Oncology, University of Washington Medicine, Seattle, WA
6Clinical Hematology, Centre Hospitalier Universitaire, University of Liège, Liège, Belgium
7University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
8First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
9Incyte Biosciences International Sàrl, Morgues, Switzerland
10Incyte Biosciences International Sàrl, Morges, Switzerland
11Incyte Corporation, Wilmington, DE
12Department of Internal Medicine I Oncology and Hematology, University Hospital Cologne, Cologne, Germany
13Department of Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany

Toby A. Eyre1*, Nirav N. Shah, MD2, Steven Le Gouill3, Martin H. Dreyling, MD, PhD4, Elisabeth Vandenberghe, MD, PhD5, Wojciech Jurczak, MD, PhD6*, Yucai Wang, MD, PhD7, Chan Yoon Cheah8, Mitul D. Gandhi, MD9, Christopher H. Chay, MD10*, Jeff P. Sharman, MD11, David Jacob Andorsky, MD12, Ming Yin13*, Minna Balbas13*, Jennifer Kherani13* and Michael L. Wang, MD14

1Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
2Medical College of Wisconsin, Milwaukee, WI
3Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France
4Department of Internal Medicine III, LMU Hospital, Munich, Germany
5Hope Directorate St. James Hospital, Dublin, Ireland
6Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland
7Division of Hematology, Mayo Clinic, Rochester, MN
8Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
9Virginia Cancer Specialists, Fairfax, VA
10Messino Cancer Centers, Asheville, NC
11Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR
12Rocky Mountain Cancer Centers, US Oncology Research, Boulder, CO
13Loxo Oncology at Lilly, Stamford, CT
14University of Texas MD Anderson Cancer Center, Houston, TX

Paul A. Hamlin, MD1, Manish R. Patel, MD2, Don Stevens, MD3, Brian T. Hess, MD4, Javier Munoz, MD, MS, MBA, FACP5, Tatyana A. Feldman, MD6, Sonali M. Smith, MD7, Greg P. Coffey, PhD8*, Muhtarjan Osman, PhD8*, Jaymes S Holland, PharmD8*, Cristina B Guzman, MBA, MD8 and Stephen D. Smith, MD9

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL
3Norton Health Care, Louisville, KY
4Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
5Banner MD Anderson Cancer Center, Gilbert, AZ
6John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
7The University of Chicago Medical Center, Chicago, IL
8Alexion, AstraZeneca Rare Disease, Boston, MA
9University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA

Alvaro J. Alencar, MD1, Lindsey E. Roeker, MD2, Marc Hoffmann, MD3, Guru Subramanian Guru Murthy, MD4*, Vishalkumar Patel5*, Nora C. Ku, MD5*, James M. Pauff, MD, PhD5, Toby A. Eyre6*, Wojciech Jurczak, MD, PhD7* and Steven Le Gouill8

1Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
2Memorial Sloan Kettering Cancer Center, New York, NY
3Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Overland Park, KS
4Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
5Loxo Oncology at Lilly, Stamford, CT
6Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
7Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
8Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France

Paul M. Barr, MD1, Hongli Li, MS2*, Brian K. Link, MD3, Christopher R. Flowers4, Richard Burack, MD, PhD5, Heiko Schöder, MD6*, Michael L. Leblanc, PhD2*, Oliver Weigert, MD7, Alex F. Herrera, MD8, David M. Weinstock, MD9, John P. Leonard, MD10, Brad S. Kahl, MD11*, Sonali M. Smith, MD12 and Jonathan W. Friedberg, MD13

1University of Rochester, Rochester, NY
2SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
3Department of Medicine, University of Iowa, Iowa City, IA
4Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
5Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Harvard Medical School, Boston, MA
10Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
11Siteman Cancer Center, Washington University, St Louis, MO
12Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
13Wilmot Cancer Institute, University of Rochester, Rochester, NY

Nicole McLaughlin1*, Jonas Paludo, MD2, Yucai Wang, MD, PhD2, David J. Inwards, MD2, Nora Bennani, M.D.2, Gita Thanarajasingam, MD2, Jose C. Villasboas, MD2, Grzegorz S. Nowakowski, MD2, Luis F. Porrata, MD2, Carrie A. Thompson, MD2, Ivana N. Micallef, MD2, Patrick B. Johnston, M.D., Ph.D.2, Thomas E. Witzig, MD2, Thomas M. Habermann, MD2 and Stephen M. Ansell, MD, PhD2

1Department of Internal Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN

Carlo Visco, MD1*, Valentina Tabanelli2*, Claudia Peracchio3*, Andrea Evangelista4*, Maria Chiara Tisi, MD5*, Anna Merli6*, Costanza Fraenza, MD7*, Stefano Fiori, MD2*, Alessandro Re, MD8*, Claudia Castellino9*, Vittorio Ruggero Zilioli, MD10*, Francesco Piazza11, Paolo Corradini, MD12, Stefan Hohaus, MD13*, Gerardo Musuraca14*, Valeria Ferla15*, Benedetta Puccini, MD16*, Federica Cavallo, MD, PhD17*, Filippo Ballerini18*, Roberta Sciarra, MD19*, Alice Di Rocco20*, Annalisa Arcari21*, Carola Boccomini, MD22*, Francesco Merli, MD23*, Guido Gini, MD24, Monica Tani, MD25*, Riccardo Bruna26*, Vincenzo Pavone27*, Andrés J M Ferreri, MD28, Armando Santoro29*, Caterina Patti30*, Giacomo Loseto, MD31*, Marco Ladetto, MD32, Michele Merli, MD33*, Michele Spina, MD34, Pier Luigi Zinzani, MD, PhD35, Pietro Maria Stefani36*, Sara Veronica Usai37*, Caterina Stelitano, MD38*, Stefano Volpetti39*, Stefano A Pileri2 and Monica Balzarotti, MD40*

1Department of Medicine, Section of Hematology, University of Verona, Verona, ITA
2Hematopathology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
3FIL, Fondazione Italiana Linfomi, Alessandria, Italy
4Città Della Salute E Della Scienza, Torino, ITA
5Department of Cell Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy
6Ospedale degli Infermi, Rimini, ITA
7Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
8Department of Hematology, ASST Spedali Civili di Brescia, Brescia, ID, Italy
9Hematology Division, Santa Croce and Carle Hospital, Cuneo, Italy
10Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, IT-MI, Italy
11Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy
12Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
13University Policlinico Gemelli Foundation, IRCCS, Catholic University of the Sacred Heart, Roma, Italy
14Division of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
15FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, ITA
16Lymphoma Unit, Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
17Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
18IRCCS Ospedale Policlinico San Martino, Clinic of Hematology, Department of Internal Medicine (DiMI), Genova, Italy
19Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
20Department of Translational and Precision Medicine, Policlinico Umberto I, Roma, Italy
21Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
22Division of Haematology, Città della Salute e della Scienza, Turin, Italy
23Clinics and Public Health, Arcispedale S.Maria Nuova, University of Modena e Reggio Emilia, Hematology Division, Department of Diagnostic Medicine, Reggio Emilia, Italy
24Hematology, Department of Clinical and Molecular Sciences, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy
25Hematology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy
26Division of Hematology, Ospedale Maggiore Della Carità, Novara, Italy
27Hematology, "Card. G. Panico" Hospital, Tricase, Italy
28Onco-Hematology Department, Fondazione Centro San Raffaele, Milan, Italy
29Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas University, Milan, Italy
30Division of Onco-Hematology, Azienda Villa Sofia Cervello, Palermo, Italy
31Division of Hematology, IRCCS Ospedale Oncologico Giovanni Paolo II, Bari, Italy
32Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, Alessandria, Italy
33Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria, Varese, Italy
34Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy
35University of Bologna, Istituto Di Ematologia, Bologna, Italy
36Ca' Foncello Hospital, Haematology Unit,, Treviso, Italy
37Ospedale Businco, S.C Ematologia e CTMO, Cagliari, Italy
38Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, RC, ITA
39Clinic of Hematology, Presidio Ospedaliero Universitario "Santa Maria della Misericordia” di Udine, ASUFC, Udine, Italy
40Unit of Hematology, Humanitas Clinical and Research Center, Rozzano, Italy

Judith Trotman, FRACP1, Peter Presgrave, MBBS, FRACP, FRCPA2*, Duncan P. Carradice, MBBS, FRCPA, FRACP3*, Douglas Stuart Lenton, FRACP, FRCPA4,5*, Maher Gandhi, PhD, FRACP6*, Tara Cochrane, MBBS, FRCPA, FRACP7, Xavier Badoux, MBBS FRACP FRCPA8*, Gloria Nkhoma, BSc (Pharm)9*, Belinda Butcher, BSci, MBiostat, PHD10,11*, Michael Fulham, FRACP12* and Anna Johnston, MBBS, FRACP, FRCPA13,14*

1Haematology, Concord Repatriation General Hospital, University of Sydney, Concord, Australia
2University of Wollongong, Wollongong, Australia
3Department of Haematology and Medical Oncology, Western Health and University of Melbourne, St Albans, Australia
4Orange Hospital, Orange, NSW, AUS
5University of Sydney, Orange, Australia
6Princess Alexandra Hospital, Brisbane, Australia
7Department of Haematology, Gold Coast University Hospital, Southport, Australia
8University of New South Wales, Kogarah, Australia
9Australasian Leukaemia and Lymphoma Group, Richmond, Australia
10WriteSource Medical Pty Ltd, Lane Cove, Australia
11University of New South Wales, Sydney, Australia
12University of Sydney, Camperdown, Australia
13Department of Hematology, Royal Hobart Hospital, Hobart, Australia
14University of Tasmania, Hobart, Australia

Yucai Wang, MD, PhD1, Melissa C. Larson, MS2*, Alessia Castellino, MD3*, Matthew J. Maurer, MS, DMSc2, Andrew L. Feldman, MD4, Sergei Syrbu, MD, PhD5*, Brian K. Link, MD6, Umar Farooq, MD6, David J. Inwards, MD1, Jonas Paludo, MD1, Thomas E. Witzig, MD1, Thomas M. Habermann, MD1, James R. Cerhan, MD, PhD2 and Grzegorz S. Nowakowski, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Department of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Department of Pathology, University of Iowa, Iowa City, IA
6Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA

Wojciech Jurczak, MD, PhD1*, Pier Luigi Zinzani, MD2, David Cunningham, MD, FRCP, FMedSci3,4*, Michel Azoulay, MD, MBA5*, Wenying Huang6*, Weiming Xu, MD, PhD6* and Vincent Ribrag, MD7

1National Research Institute of Oncology, Krakow, Poland
2Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
3The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
4The Royal Marsden NHS Foundation Trust, London, United Kingdom
5Kyowa Kirin Co., Princeton, NJ
6MEI Pharma, San Diego, CA
7Institut Gustave Roussy, Villejuif, France

Yi Xu, BSc1*, Matthew Chan, MD, FRCPC2,3*, Tom Pickles, MD, MRCP, FRCPC2,3*, Jessica Chan, MD, MPH, PhD, FRCPC2,3*, Laurie H. Sehn, MD1,4,5, David W. Scott, PhD, MD, FRACP, FRCPA1,4,5, Diego Villa, MD, MPH, FRCPC1,4,5, Alina S. Gerrie, MD, MPH, FRCPC1,4,5, Kerry J. Savage, MD, MSc, FRCPC1,4,5 and Andrea C. Lo, MD2,3,5*

1Department of Medicine, University of British Columbia, Vancouver, BC, Canada
2Department of Radiation Oncology, BC Cancer – Vancouver, Vancouver, BC, Canada
3Department of Surgery, University of British Columbia, Vancouver, BC, Canada
4Department of Medical Oncology, BC Cancer – Vancouver, Vancouver, BC, Canada
5Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada

Paolo Strati, MD1, Dominik Chraniuk, MD2*, Eva González-Barca, MD, PhD3*, Michal Taszner, MD4*, Rathi Pillai, MD5*, Caly Chien, PhD5*, Shivani Nanda, MS5*, Mark Rudinski, PhD5*, Vijayvel Jayaprakash, MD, PhD5*, Marjo Hahka-Kemppinen, MD, PhD5 and Marek Kania, MD, MBA5*

1Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
22Nasz Lekarz Przychodnie Medyczne, Torun, POL
3Department of Hematology, Institut Catalá d’Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
4Medical University of Gdansk, Gdansk, Poland
5HUTCHMED International, Florham Park, NJ

Pallawi Torka, MD1, Swetha Kambhampati, MD2, Alexandra Muir, BSN, RN2*, Kirsten Orand2*, Lynne Smith2*, Alex F. Herrera, MD3, Lionel Lewis4*, Francisco J. Hernandez-Ilizaliturri, MD5, Lu Chen, PhD6* and Alexey V. Danilov, MD, PhD7

1Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2City of Hope National Medical Center, DUARTE, CA
3City of Hope, Duarte, CA
4The Norris Cotton Cancer Center At Dartmouth-Hitchcock Medical Center Lebanon,, Lebanon, NH
5Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
6Department of Information Sciences, City of Hope, Duarte
7City of Hope Comprehensive Cancer Center, Duarte, CA

Yuqin Song, MD1*, Zhitao Ying, MD1*, Haiyan Yang2, Ye Guo, MD3*, Wenyu Li, MD4, Dehui Zou5*, Jianqiu Wu, MD6*, Su Yang7*, Pian Zhang7*, Meilin Ma7*, Zisong Zhou7*, Hongxia Zheng7* and Jun Zhu, B.S.1

1Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
2Department of Medical Oncology, Institute of Cancer and Basic Medicine(IBMC), Chinese Academy of Sciences, Hangzhou, China
3Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
4Department of Lymphoma, Guangdong Academy of Science, Guangdong Provincial Peoples Hospital, Guangdong, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
6Department of Medical Oncology, Jiangsu Institute of Cancer Research, Jiangsu Red Cross Cancer Center, Jiangsu Cancer Hospital, The Affiliated Hospital of Nanjing Medical University, Nanjing, China
7JW Therapeutics (Shanghai) Co. Ltd, Shanghai, China

Eduardo Saul, MD1, Juan Pablo Alderuccio, MD2, Isildinha M. Reis, PhD3*, Wei Zhao, MD, MS3*, Sunil G. Iyer, MD2*, Gregor Rodriguez, MD4, Amrita Desai, MD, MPH5*, Derek Isrow, MD, PhD6*, Arnold M. Markoe, MD6* and Izidore S. Lossos, MD2

1Department of Internal Medicine, Jackson Memorial Hospital/University of Miami, Miller School of Medicine, Miami, FL
2Division of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
3Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
4Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
5Department of Hematology-Oncology, OHSU Knight Cancer Institute, Oregon Health Sciences University, Portland, OR
6Division of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL

Giuseppe Rossi, MD1, Henry Miles Prince2*, Constantine S. Tam, MBBS, MD3*, Matthew Ku, MBBS, FRACP, FRCPA, PhD4, Catherine Thieblemont, MD, PhD5, Leslie L. Popplewell, MD, FACP6, Martin Wermke, MD7*, Corinne Haioun, MD, PhD8*, Nicole Wong Doo, MBBS, MD, FRACP, FRCPA9*, Andreas Viardot, MD10, Andrés J M Ferreri, MD11, Silvia Ferrari, MD12*, Hansen L. Wong, PhD13*, Priti Kadu14*, Gerhard Zugmaier, MD, PhD15, Yi Zeng16 and Alessandro Rambaldi, MD, PhD12,17*

1Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
2Epworth Healthcare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
3St. Vincent's Hospital Melbourne, Melbourne, Australia
4Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia
5APHP, Hemato-Oncology, Hôpital Saint-Louis, Paris, France
6Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
7Medical Faculty, NCT/UCC Early Clinical Trial Unit, Technical University Dresden, Dresden, Germany
8Hôpital Henri Mondor, Créteil, France
9Concord Clinical School, Concord Hospital University of Sydney, Sydney, Australia
10Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
11IRCCS San Raffaele Scientific Institute, Milan, Italy
12Department of Oncology and Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
13Amgen Inc., South San Francisco, CA
14IQVIA RDS (India) Private Limited, Bangalore, Karnataka, India
15Amgen Research GmbH, Munich, Germany
16Amgen Development, Thousand Oaks, CA
17University of Milan, Milan, Italy

Karthik Chamarti, MBBS1, John William Thomas2*, Mayur Narkhede, MD3 and Gaurav Goyal, MD3

1Department of Internal Medicine, Texas Tech University Health Science Center - Permian Basin, Odessa, TX
2Tinsley Harrison Internal Medicine Residency Program, University of Alabama at Birmingham, Birmingham, AL
3Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

*signifies non-member of ASH